Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM),
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …

Background and objective External evaluation is an important issue in the population
pharmacokinetic analysis of antibiotics. The purpose of this review was to summarize the …

Antimicrobial resistance is a major global health challenge. As few new efficacious
antibiotics will become available in the near future, peptide antibiotics continue to be major …

Predicting drug exposures using population pharmacokinetic models through Bayesian
forecasting software can improve individual pharmacokinetic/pharmacodynamic target …

Vancomycin is widely used in pediatric patients, however, large inter-and intraindividual
variability are observed in vancomycin pharmacokinetics, affecting proper therapeutic …

Although tigecycline is widely used in clinical practice, its efficiency and optimal dosage
regimens remain controversial. The purpose of this article was to help guide tigecycline …

Bayesian therapeutic drug monitoring (TDM) software uses a reported pharmacokinetic (PK)
model as prior information. Since its estimation is based on the Bayesian method, the …

Background There are conflicts in guideline recommendations about the value and range of
vancomycin trough concentration during therapeutic drug monitoring (TDM). This …

As one of the efficient techniques for TDM, the population pharmacokinetic (popPK) model
approach for dose individualization has been developed due to the rapidly growing …

The recently released revised vancomycin consensus guideline endorsed area under the
concentration‐time curve (AUC) guided monitoring. Means to AUC‐guided monitoring …